Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Renal Failure

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    March 2024
  1. GOLDFARB DS
    Nephrologists should talk to their patients about climate change.
    Curr Opin Nephrol Hypertens. 2024;33:170-173.
    PubMed    


  2. ALEXIUK M, Tangri N
    Prediction models for earlier stages of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Mar 1. doi: 10.1097/MNH.0000000000000981.
    PubMed     Abstract available


    February 2024
  3. HOLLIDAY MW JR, Frost L, Navaneethan SD
    Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression.
    Curr Opin Nephrol Hypertens. 2024 Feb 26. doi: 10.1097/MNH.0000000000000976.
    PubMed     Abstract available


  4. HUNDEMER GL, Akbari A, Sood MM
    Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?
    Curr Opin Nephrol Hypertens. 2024 Feb 26. doi: 10.1097/MNH.0000000000000971.
    PubMed     Abstract available


    January 2024
  5. SPENCER A, Lavenburg LM, Sanders AP, Shah AD, et al
    Clearing the air: a review of the effects of air pollution on dialysis outcomes.
    Curr Opin Nephrol Hypertens. 2024 Jan 12. doi: 10.1097/MNH.0000000000000968.
    PubMed     Abstract available


  6. DOBRE MA, Ahlawat S, Schelling JR
    Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives.
    Curr Opin Nephrol Hypertens. 2024 Jan 8. doi: 10.1097/MNH.0000000000000952.
    PubMed     Abstract available


  7. RIZZOLO K, Shen JI
    Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals.
    Curr Opin Nephrol Hypertens. 2024;33:26-33.
    PubMed     Abstract available


  8. TAN SK, Pinzon-Cortes JA, Cooper ME
    Novel pharmacological interventions for diabetic kidney disease.
    Curr Opin Nephrol Hypertens. 2024;33:13-25.
    PubMed     Abstract available


    December 2023
  9. MIRMOHAMMADALI SN, Gallant KMH, Biruete A
    Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder.
    Curr Opin Nephrol Hypertens. 2023 Dec 14. doi: 10.1097/MNH.0000000000000961.
    PubMed     Abstract available


  10. BANSAL AD, Patel AA
    Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely.
    Curr Opin Nephrol Hypertens. 2023 Dec 4. doi: 10.1097/MNH.0000000000000959.
    PubMed     Abstract available


    November 2023
  11. BISSINGER R, Qadri SM, Artunc F
    Eryptosis: a driver of anemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2023 Nov 22. doi: 10.1097/MNH.0000000000000957.
    PubMed     Abstract available


  12. SPASIANO A, Benedetti C, Gambaro G, Ferraro PM, et al
    Predictive models in chronic kidney disease: essential tools in clinical practice.
    Curr Opin Nephrol Hypertens. 2023 Nov 9. doi: 10.1097/MNH.0000000000000950.
    PubMed     Abstract available


  13. LUCAS B, Taal MW
    Blood pressure targets in chronic kidney disease: still no consensus.
    Curr Opin Nephrol Hypertens. 2023;32:497-501.
    PubMed     Abstract available


    October 2023
  14. PHUA E, Shen Y
    The climate impact of dialysis.
    Curr Opin Nephrol Hypertens. 2023 Oct 30. doi: 10.1097/MNH.0000000000000940.
    PubMed     Abstract available


    August 2023
  15. CASTLE EM, Billany RE, Lightfoot CJ, Annema C, et al
    Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?
    Curr Opin Nephrol Hypertens. 2023 Aug 24. doi: 10.1097/MNH.0000000000000923.
    PubMed     Abstract available


    June 2023
  16. SINGH S
    Medication safety in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2023 Jun 9. doi: 10.1097/MNH.0000000000000907.
    PubMed     Abstract available


    May 2023
  17. ALICIC RZ, Neumiller JJ, Tuttle KR
    Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2023 May 5. doi: 10.1097/MNH.0000000000000894.
    PubMed     Abstract available


    April 2023
  18. KURO-O M
    Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Curr Opin Nephrol Hypertens. 2023 Apr 13. doi: 10.1097/MNH.0000000000000890.
    PubMed     Abstract available


    March 2023
  19. LAFAVERS K, Garimella PS
    Uromodulin: more than a marker for chronic kidney disease progression.
    Curr Opin Nephrol Hypertens. 2023 Mar 10. doi: 10.1097/MNH.0000000000000885.
    PubMed     Abstract available


    February 2023
  20. NAST CC
    Chronic kidney disease with unknown cause across the global spectrum.
    Curr Opin Nephrol Hypertens. 2023 Feb 10. doi: 10.1097/MNH.0000000000000874.
    PubMed     Abstract available


    January 2023
  21. HANNA RM, Ahdoot RS, Rhee CM, Tantisattamo E, et al
    New and old approaches to nutritional management of acute and chronic glomerulonephritis.
    Curr Opin Nephrol Hypertens. 2023;32:76-80.
    PubMed     Abstract available


  22. EDWARDS DP, Kalantar-Zadeh K, Streja E, Ahdoot RS, et al
    Practicing health equity in involuntary discharges to overcome disparities in dialysis and kidney patient care.
    Curr Opin Nephrol Hypertens. 2023;32:49-57.
    PubMed     Abstract available


  23. FRIDELL JA, Stratta RJ
    Modern indications for referral for kidney and pancreas transplantation.
    Curr Opin Nephrol Hypertens. 2023;32:4-12.
    PubMed     Abstract available


  24. TANTISATTAMO E, Hanna RM, Kalantar-Zadeh K
    Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation.
    Curr Opin Nephrol Hypertens. 2023;32:1-3.
    PubMed    


    November 2022
  25. ELDEHNI MT
    Frailty, multimorbidity and sarcopaenia in haemodialysis patients.
    Curr Opin Nephrol Hypertens. 2022;31:560-565.
    PubMed     Abstract available


  26. PENNY JD, Moradshahi M, McIntyre CW
    Assessment of microcirculatory function during hemodialysis.
    Curr Opin Nephrol Hypertens. 2022;31:553-559.
    PubMed     Abstract available


    October 2022
  27. NISSAISORAKARN V, Nissaisorakarn P, Kantachuvesiri S
    The current therapeutic approach for anaemia after kidney transplant.
    Curr Opin Nephrol Hypertens. 2022 Oct 12. pii: 00041552-990000000-00033.
    PubMed     Abstract available


    September 2022
  28. POZO GARCIA L, Thomas SS, Rajesh H, Navaneethan SD, et al
    Progress in the management of patients with diabetes and chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:456-463.
    PubMed     Abstract available


  29. UPPAL NN, Corona A, Fishbane S
    Pruritus in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:435-441.
    PubMed     Abstract available


  30. ALI S, Navaneethan SD, Virani SS, Gregg LP, et al
    Revisiting diuretic choice in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:406-413.
    PubMed     Abstract available


    August 2022
  31. KULA A, Bansal N
    Applications of cardiac biomarkers in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Aug 5. pii: 00041552-990000000-00024.
    PubMed     Abstract available


    July 2022
  32. TAAL MW
    Defining improvement in chronic kidney disease: regression and remission.
    Curr Opin Nephrol Hypertens. 2022 Jul 25. pii: 00041552-990000000-00023.
    PubMed     Abstract available


  33. MARTIN A, Isakova T
    Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease-mineral and bone disorder.
    Curr Opin Nephrol Hypertens. 2022;31:303-305.
    PubMed    


    June 2022
  34. DUQUE EJ, Elias RM, Moyses RMA
    Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00008.
    PubMed     Abstract available


  35. AGORO R, White KE
    Anemia and fibroblast growth factor 23 elevation and chronic kidney disease: homeostatic interactions and emerging therapeutics.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00005.
    PubMed     Abstract available


  36. SMOUT D, Jorgensen HS, Cavalier E, Evenepoel P, et al
    Clinical utility of bone turnover markers in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00002.
    PubMed     Abstract available


  37. DORR K, Kainz A, Oberbauer R
    Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00001.
    PubMed     Abstract available


    March 2022
  38. WEINHANDL ED
    The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated.
    Curr Opin Nephrol Hypertens. 2022;31:185-190.
    PubMed     Abstract available


    February 2022
  39. CANNEY M, Sood MM, Hundemer GL
    Contemporary risk prediction models in chronic kidney disease: when less is more.
    Curr Opin Nephrol Hypertens. 2022 Feb 25. pii: 00041552-900000000-98931.
    PubMed     Abstract available


  40. TANGRI N, Ferguson TW
    Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury.
    Curr Opin Nephrol Hypertens. 2022 Feb 21. pii: 00041552-900000000-98932.
    PubMed     Abstract available


  41. RAJ R
    Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Feb 14. pii: 00041552-900000000-98934.
    PubMed     Abstract available


  42. TAN H, Xu J, Liu Y
    Ageing, cellular senescence and chronic kidney disease: experimental evidence.
    Curr Opin Nephrol Hypertens. 2022 Feb 9. pii: 00041552-900000000-98935.
    PubMed     Abstract available


    January 2022
  43. MUREA M, Flythe JE, Anjay R, Emaad AM, et al
    Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one.
    Curr Opin Nephrol Hypertens. 2022;31:92-99.
    PubMed     Abstract available


  44. SUMIDA K, Lau WL, Kalantar-Zadeh K, Kovesdy CP, et al
    Novel intestinal dialysis interventions and microbiome modulation to control uremia.
    Curr Opin Nephrol Hypertens. 2022;31:82-91.
    PubMed     Abstract available


  45. TANTISATTAMO E, Hanna RM, Kalantar-Zadeh K
    Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era.
    Curr Opin Nephrol Hypertens. 2022;31:1-5.
    PubMed    


    December 2021
  46. BLEYER AJ
    Factors that lead to dialysis as the preferred treatment modality for patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Dec 24. pii: 00041552-900000000-98940.
    PubMed     Abstract available


  47. LEON SJ, Tangri N
    Can chronic kidney disease lead to chronic heart failure, and does worsening chronic heart failure lead to chronic kidney disease progression.
    Curr Opin Nephrol Hypertens. 2021 Dec 24. pii: 00041552-900000000-98941.
    PubMed     Abstract available


    November 2021
  48. OTOBE Y, Rhee CM, Nguyen M, Kalantar-Zadeh K, et al
    Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients.
    Curr Opin Nephrol Hypertens. 2021 Nov 11. pii: 00041552-900000000-98950.
    PubMed     Abstract available


  49. AHDOOT RS, Kalantar-Zadeh K, Burton JO, Lockwood MB, et al
    Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98960.
    PubMed     Abstract available


  50. KALANTAR-ZADEH K, Rhee CM, Joshi S, Brown-Tortorici A, et al
    Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98952.
    PubMed     Abstract available


  51. TANTISATTAMO E, Hamiduzzaman A, Sohn P, Ahdoot R, et al
    Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98955.
    PubMed     Abstract available


  52. TANTISATTAMO E, Kalantar-Zadeh K, Molnar MZ
    Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98954.
    PubMed     Abstract available


  53. RHEE CM, Kalantar-Zadeh K, Tuttle KR
    Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98953.
    PubMed     Abstract available


  54. ALSAAD R, Chen X, McAdams-DeMarco M
    The clinical application of frailty in nephrology and transplantation.
    Curr Opin Nephrol Hypertens. 2021;30:593-599.
    PubMed     Abstract available


  55. STEWART P, Stewart J
    Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability.
    Curr Opin Nephrol Hypertens. 2021;30:559-562.
    PubMed     Abstract available


    July 2021
  56. SINHA S, Raggi P, Chertow GM
    SNF472: mechanism of action and results from clinical trials.
    Curr Opin Nephrol Hypertens. 2021;30:424-429.
    PubMed     Abstract available


    November 2020
  57. TANTISATTAMO E, Kalantar-Zadeh K, Halleck F, Duettmann W, et al
    Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000673.
    PubMed     Abstract available


  58. ONG SC, Rhee CM
    Novel management of diabetes in kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000665.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.